Speaker illustration

Professor Karlis Trusinskis

Paul Stradins Clinical University Hospital, Riga (Latvia)

Member of:

European Society of Cardiology

Bailout inclisiran-based triple lipid-lowering therapy reduces plaque lipid content in stable coronary artery disease patients

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Pharmacology in coronary artery disease

Thumbnail

Guideline implementation: challenges and opportunities.

Event: ESC Congress 2019

Topic: European Society of Cardiology

Session: Guidelines in Daily Practice - Myocardial Revascularisation

Thumbnail

Plasma microRNA-155 predicts increased plaque vulnerability in patients with prediabetes

Event: ESC Congress 2017

Topic: CAD and comorbidities

Session: CAD and comorbidities

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb